Cases 51 - 60 of 763
PETRIE v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv01772
Plaintiff:
STEVEN PETRIE
Defendant:
AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., AUROLIFE PHARMA, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
ESTATE OF KORENE HUNGATE v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv01377
Plaintiff:
KARLYN HUNGATE and ESTATE OF KORENE HUNGATE
Defendant:
AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, AUROLIFE PHARMA, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
DAWSON v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv01159
Plaintiff:
DIANA DAWSON
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN, N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
In Re: Valsartan Losartan and Irbesartan Products
as 23-8007
Petitioner:
AUROBINDO PHARMA LTD, AUROBINDO PHARMA USA INC, AUROLIFE PHARMA LLC and others
Respondent:
CONSUMER ECONOMIC LOSS PLAINTIFFS, THIRD-PARTY PAYOR PLAINTIFFS and MEDICAL MONITORING PLAINTIFFS
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al
as 1:2023cv00926
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al
as 2:2023cv00926
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
WRIGLEY v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv00831
Plaintiff:
BYRON WRIGLEY
Defendant:
AUROBINDO PHARMA, LTD., HETERO DRUGS, LTD., HETERO LABS, LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
HALE et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv00575
Plaintiff:
WILEY HALE and STARRTRYNEA REEVES
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
PUHALLA v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2023cv00437
Plaintiff:
RUDOLPH PUHALLA
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., HUAHAI U.S. INC., PRINSTON PHARMACEUTICAL INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
MATRACHISIA v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv00341
Plaintiff:
JOHN MATRACHISIA
Defendant:
AUROBINDO PHARMA, LTD., AUROBINDO PHARMA USA, INC., AUROLIFE PHARMA, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
